scispace - formally typeset
J

Jean-Jacques Body

Researcher at Université libre de Bruxelles

Publications -  397
Citations -  21506

Jean-Jacques Body is an academic researcher from Université libre de Bruxelles. The author has contributed to research in topics: Breast cancer & Zoledronic acid. The author has an hindex of 70, co-authored 384 publications receiving 19608 citations. Previous affiliations of Jean-Jacques Body include The Breast Cancer Research Foundation & University of California, San Francisco.

Papers
More filters
Journal Article

Radioimmunoassay of calcitonin in normal human plasma: problems, perspectives and prospects.

TL;DR: Radioimmunoassay of calcitonin in normal human plasma is hindered by immunochemical heterogeneity in plasma, variable susceptibility of antisera to non-specific factors, limited assay sensitivity, and other problems.
Journal ArticleDOI

Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications

TL;DR: In this article, drugs used for the prevention and the treatment of osteoporosis exert various favorable and unfavourable extra-skeletal effects whose importance is increasingly recognized notably for treatment selection.
Journal ArticleDOI

Bisphosphonates for metastatic bone pain.

TL;DR: Preliminary follow-up data on the pamidronate trial suggest prolongation of survival in the patients receiving second or subsequent lines of chemotherapy, and intravenous bisphosphonates can also exert clinically relevant analgesic effects in patients with metastatic bone pain.
Journal ArticleDOI

Protein production by osteoblasts: modulation by breast cancer cell-derived factors.

TL;DR: It is shown that the net collagen amount produced in vitro by normal human osteoblasts and osteoblast-like cells was significantly reduced by culture medium conditioned by several BCC lines, including three newly isolated ones, suggesting that besides the eroding action of osteoclasts, BCC- and osteOBlast-derived MMPs and serine proteinases might play a direct role in bone collagen degradation in TIO.
Journal ArticleDOI

Treatment with steroids of a giant cell granuloma of the maxilla

TL;DR: This case report of giant cell granuloma involving the maxilla is of particular interest for two reasons: the locally aggressive clinical course contrasting with the diagnosis of a benign disease and the spectacular, although transient, response under steroid treatment.